Marc Maynadié

20.0k total citations · 2 hit papers
132 papers, 5.5k citations indexed

About

Marc Maynadié is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, Marc Maynadié has authored 132 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 44 papers in Hematology and 34 papers in Oncology. Recurrent topics in Marc Maynadié's work include Lymphoma Diagnosis and Treatment (44 papers), Acute Lymphoblastic Leukemia research (29 papers) and Acute Myeloid Leukemia Research (27 papers). Marc Maynadié is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Acute Lymphoblastic Leukemia research (29 papers) and Acute Myeloid Leukemia Research (27 papers). Marc Maynadié collaborates with scholars based in France, Italy and Spain. Marc Maynadié's co-authors include Rafael Marcos‐Gragera, Roberta De Angelis, Otto Visser, Milena Sant, Anne‐Marie Bouvier, Claudia Allemani, Fabrice Carrat, Laurent Beaugerie, Carmen Ţereanu and Tony Petrella and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marc Maynadié

125 papers receiving 5.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

2009 762 citations Anne‐Marie Bouvier, Marc Maynadié et al. profile →
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

2010 665 citations Marc Maynadié et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Maynadié France	36	1.8k	1.7k	1.4k	1.2k	1.1k	132	5.5k
Éric Deconinck France	40	1.6k 0.9×	1.7k 1.0×	1.8k 1.2×	1.0k 0.8×	588 0.5×	221	4.9k
Xavier Troussard France	35	1.9k 1.1×	1.3k 0.8×	1.1k 0.8×	2.0k 1.6×	534 0.5×	244	4.6k
Jean‐Yves Cahn France	37	2.6k 1.4×	2.9k 1.7×	4.3k 3.0×	1.7k 1.3×	519 0.5×	127	8.4k
Dominique Bordessoule France	39	2.3k 1.3×	2.2k 1.3×	2.3k 1.6×	1.9k 1.6×	335 0.3×	188	6.3k
Joseph O. Moore United States	42	997 0.5×	1.9k 1.1×	3.3k 2.3×	1.5k 1.2×	363 0.3×	148	6.6k
Roy B. Jones United States	43	735 0.4×	2.5k 1.5×	3.4k 2.4×	1.2k 0.9×	259 0.2×	176	6.6k
Martin F. Fey Switzerland	49	1.2k 0.6×	3.0k 1.8×	2.1k 1.5×	927 0.8×	462 0.4×	189	8.0k
Jesús María Hernández‐Rivas Spain	49	2.2k 1.2×	2.2k 1.3×	4.2k 2.9×	2.6k 2.1×	322 0.3×	318	9.2k
Daniel R. Couriel United States	45	644 0.4×	1.8k 1.0×	4.7k 3.3×	895 0.7×	615 0.6×	155	6.6k
David D. Hurd United States	35	990 0.5×	1.6k 0.9×	2.4k 1.7×	808 0.7×	381 0.3×	159	4.8k

Countries citing papers authored by Marc Maynadié

Since Specialization

Citations

This map shows the geographic impact of Marc Maynadié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Maynadié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Maynadié more than expected).

Fields of papers citing papers by Marc Maynadié

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Maynadié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Maynadié. The network helps show where Marc Maynadié may publish in the future.

Co-authorship network of co-authors of Marc Maynadié

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Maynadié. A scholar is included among the top collaborators of Marc Maynadié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Maynadié. Marc Maynadié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orazio, Sébastien, Cédric Rossi, S. Gauthier, et al.. (2025). Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based Study. Cancers. 17(4). 711–711.

Guidez, Fabien, Cyril Fournier, Anne Largeot, et al.. (2024). Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia. Communications Biology. 7(1). 753–753. 1 indexed citations

Boulin, Mathieu, Amélie Cransac, Marc Maynadié, et al.. (2022). COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 19(7). 3957–3957. 5 indexed citations

Mounier, Morgane, Louis Arnould, Catherine Creuzot‐Garcher, et al.. (2021). Heamatological malignancies in giant cell arteritis: a French population-based study. Lara D. Veeken. 60(11). 5408–5412. 5 indexed citations

Maynadié, Marc. (2018). Maintenir le haut niveau scientifique des étudiants. Revue Francophone des Laboratoires. 2019(508). 1–1. 1 indexed citations

Gouill, Steven Le, Rémy Gressin, Aurélie Bertaut, et al.. (2017). Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries. Journal of Cancer Research and Clinical Oncology. 144(4). 629–635. 9 indexed citations

Guy, Julien, et al.. (2017). A 5‐color flow cytometric method for extended 8‐part leukocyte differential. Cytometry Part B Clinical Cytometry. 92(6). 498–507. 2 indexed citations

Rossi, Cédric, Jérémie Jegu, Morgane Mounier, et al.. (2015). Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leukemia & lymphoma. 56(10). 2876–2882. 16 indexed citations

Bouvier, Anne‐Marie, P. Arveux, Isabelle Baldi, et al.. (2013). What are the delays in providing cancer care in France? A study based on data from cancer registries.. 581–589. 1 indexed citations

10.

Guy, Julien, Iléana Antony‐Debré, Emmanuel Benayoun, et al.. (2013). Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia. British Journal of Haematology. 161(4). 551–555. 27 indexed citations

11.

Cocco, Pierluigi, Giannina Satta, Mariagrazia Zucca, et al.. (2012). Lymphoma risk and occupational exposure to pesticides: results of the Epilymph study. Occupational and Environmental Medicine. 70(2). 91–98. 71 indexed citations

12.

Guy, Julien, Iléana Antony‐Debré, Isabelle Arnoux, et al.. (2012). Flow Cytometry Thresholds of Myeloperoxidase Detection to Discriminate Between Acute Lymphoblastic or Myeloblastic Leukemia. Blood. 120(21). 1450–1450. 2 indexed citations

13.

Mounier, Morgane, Peter Johansson, Cédric Rossi, et al.. (2012). Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population‐based study of 327 patients. British Journal of Haematology. 160(2). 251–254. 52 indexed citations

14.

Maillefert, Jean-Françis, Xavier Puéchal, Géraldine Falgarone, et al.. (2010). Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis. Joint Bone Spine. 77(6). 558–563. 24 indexed citations

15.

Arnoulet, Christine, Marie C. Béné, Françoise Durrieu, et al.. (2009). Four‐ and five‐color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: A reference document based on a systematic approach by the GTLLF and GEIL. Cytometry Part B Clinical Cytometry. 78B(1). 4–10. 49 indexed citations

16.

Danzon, Arlette, et al.. (2009). Incidence and survival of gastric non-Hodgkin's lymphoma: A population-based study from the Association of the French Cancer Registries (FRANCIM). Acta Oncologica. 48(7). 977–983. 4 indexed citations

17.

Bayer, Jan, et al.. (2006). Thematic workshop on fluorescence compensation settings in multicolor flow cytometry. Cytometry Part B Clinical Cytometry. 72B(1). 8–13. 26 indexed citations

18.

Maynadié, Marc, et al.. (2004). Peripheral Blood Lymphocytes Subpopulations and Apoptotic Markers in Patients with Lymphoid Malignancies and in Controls: An Epidemiologic Case-Control Study.. Blood. 104(11). 3858–3858. 3 indexed citations

19.

Sgro, C, et al.. (2000). Increase therapy-related leukemia secondary to breast cancer. Leukemia. 14(6). 1014–1017. 45 indexed citations

20.

Quantin, Catherine, Michał Abrahamowicz, Lionel Mannone, et al.. (1999). Testing the proportional hazards assumption in medical survival studies--application to a population-based study of acute myeloid leukaemia.. PubMed. 4(2). 83–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact